BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32860921)

  • 21. Erosive lichen planus on an atypical site mimicking a factitial dermatitis.
    Schepis C; Lentini M; Siragusa M
    Acta Derm Venereol; 2010 Mar; 90(2):185-6. PubMed ID: 20169305
    [No Abstract]   [Full Text] [Related]  

  • 22. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
    Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R
    Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Refractory Waldenström's macroglobulinaemia responsive to 2-chlorodeoxyadenosine and mycophenolate mofetil.
    Gladstone DE
    Leuk Res; 2008 Sep; 32(9):1487-8. PubMed ID: 18378308
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of cutaneous lichen planus with thalidomide.
    Moura AK; Moure ER; Romiti R
    Clin Exp Dermatol; 2009 Jan; 34(1):101-3. PubMed ID: 19076811
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of immunosuppressive treatments based on mycophenolate mofetil in posttransplantation renal surgical complications.
    Herrero JC; Andrés A; Leiva O; Diaz R; Polo G; Aguirre F; Villacampa F; Rodicio JL; Gonzalez E; Morales JM; Praga M
    Transplant Proc; 2002 Feb; 34(1):96. PubMed ID: 11959201
    [No Abstract]   [Full Text] [Related]  

  • 26. Mycophenolate mofetil for the treatment of severe inflammatory external eye diseases.
    Wilkins MR; Dart JK
    Br J Ophthalmol; 2008 Apr; 92(4):578-9. PubMed ID: 18369079
    [No Abstract]   [Full Text] [Related]  

  • 27. Recalcitrant erosive flexural lichen planus: successful treatment with a combination of thalidomide and 0.1% tacrolimus ointment.
    Eisman S; Orteu CH
    Clin Exp Dermatol; 2004 May; 29(3):268-70. PubMed ID: 15115508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of steroid-resistant minimal change disease with mycophenolate mofetil.
    Mogyorósi A; Lippman HR; Feldman GM
    Am J Nephrol; 2002; 22(5-6):569-72. PubMed ID: 12381961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omission of azathioprine and mycophenolate mofetil in immunosuppressive regimen in kidney transplantation.
    Taheri M; Pourmand G; Mehrsai AR; Mansoori D
    Transplant Proc; 2003 Nov; 35(7):2752-3. PubMed ID: 14612105
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunosuppressive regimen in lung transplantation: initial intravenous mycophenolate mofetil and cyclosporine avoid cytolytic induction and allow for rapid steroid tapering.
    Fieguth HG; Simon A; Scherer M; Klesius AA; Wiedenmann DE
    Transplant Proc; 2002 Aug; 34(5):1879-80. PubMed ID: 12176611
    [No Abstract]   [Full Text] [Related]  

  • 31. Low molecular weight heparin; a novel alternative therapeutic approach for lichen planus.
    Stefanidou MP; Ioannidou DJ; Panayiotides JG; Tosca AD
    Br J Dermatol; 1999 Dec; 141(6):1040-5. PubMed ID: 10606849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
    Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
    Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
    Geilen CC; Orfanos-Boeckel H; Offermann G; Orfanos CE
    Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum.
    Hohenleutner U; Mohr VD; Michel S; Landthaler M
    Lancet; 1997 Dec; 350(9093):1748. PubMed ID: 9413469
    [No Abstract]   [Full Text] [Related]  

  • 35. Update on treatments for erosive vulvovaginal lichen planus.
    Dunaway S; Tyler K; Kaffenberger J
    Int J Dermatol; 2020 Mar; 59(3):297-302. PubMed ID: 31631346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycophenolate in dermatology.
    Liu V; Mackool BT
    J Dermatolog Treat; 2003 Dec; 14(4):203-11. PubMed ID: 14660264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erosive and generalized lichen planus responsive to azathioprine.
    Lear JT; English JS
    Clin Exp Dermatol; 1996 Jan; 21(1):56-7. PubMed ID: 8689773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of oral retinoids in treatment-resistant lichen planopilaris.
    Spano F; Donovan JC
    J Am Acad Dermatol; 2014 Nov; 71(5):1016-8. PubMed ID: 25437967
    [No Abstract]   [Full Text] [Related]  

  • 39. Mycophenolate mofetil reduces anti-HLA antibody production and cellular rejection in heart transplant recipients.
    Lietz K; John R; Schuster M; Ankersmit J; Burke E; Suciu-Foca N; Edwards N; Mancini D; Itescu S
    Transplant Proc; 2002 Aug; 34(5):1828-9. PubMed ID: 12176593
    [No Abstract]   [Full Text] [Related]  

  • 40. Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus.
    Daly I; Jain A; Reyes J; Fung J
    Transplant Proc; 2002 Aug; 34(5):1503. PubMed ID: 12176458
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.